Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ihn, H.
Right arrow Articles by Takehara, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ihn, H.
Right arrow Articles by Takehara, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

The British Journal of Rheumatology, Vol 36, 1270-1275, Copyright © 1997 by British Society for Rheumatology


ORIGINAL PAPERS

Circulating intercellular adhesion molecule-1 in the sera of patients with systemic sclerosis: enhancement by inflammatory cytokines

H Ihn, S Sato, M Fujimoto, K Kikuchi, T Kadono, K Tamaki and K Takehara
Department of Dermatology, Faculty of Medicine, University of Tokyo, Japan.

We measured serum levels of circulating intercellular adhesion molecule- 1 (cICAM-1) in patients with systemic sclerosis (SSc) and normal controls. The levels of cICAM-1 were determined by sandwich enzyme- linked immunosorbent assay in sera from 88 patients with SSc and in 20 healthy controls. In addition, these levels were examined in the supernatants of cultured peripheral blood mononuclear cells (PBMC) and dermal fibroblasts from 10 patients with SSc and 10 healthy control subjects. Serum levels of cICAM-1 were significantly higher in patients with SSc than in healthy controls. Serum cICAM-1 levels were significantly higher in patients with diffuse cutaneous SSc (dcSSc) than in patients with limited cutaneous SSc (lcSSc). These serum levels were correlated with the presence of contracture of phalanges, pulmonary fibrosis, joint involvement and increased erythrocyte sedimentation rate. The release of cICAM-1 was significantly increased in the supernatants of cultured PBMC from patients with SSc. Moreover, inflammatory cytokines (interferon-gamma, interleukin-1 and tumor necrosis factor-alpha) enhanced the release of cICAM-1 in vitro in SSc cells. These findings suggest that cICAM-1 may be involved in immune reactions in this disease.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
Y. Matsushita, M. Hasegawa, T. Matsushita, M. Fujimoto, M. Horikawa, T. Fujita, A. Kawasuji, F. Ogawa, D. A. Steeber, T. F. Tedder, et al.
Intercellular Adhesion Molecule-1 Deficiency Attenuates the Development of Skin Fibrosis in Tight-Skin Mice
J. Immunol., July 1, 2007; 179(1): 698 - 707.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
H. Ihn, K. Yamane, Y. Asano, M. Jinnin, and K. Tamaki
Constitutively phosphorylated Smad3 interacts with Sp1 and p300 in scleroderma fibroblasts
Rheumatology, February 1, 2006; 45(2): 157 - 165.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
K Yanaba, K Takehara, and S Sato
Serum concentrations of soluble P-selectin glycoprotein ligand-1 are increased in patients with systemic sclerosis: association with lower frequency of pulmonary fibrosis
Ann Rheum Dis, May 1, 2004; 63(5): 583 - 587.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
S. Cogalgil and S. Taysi
Levels of Antioxidant Proteins and Soluble Intercellular Adhesion Molecule-1 in Serum of Patients with Rheumatoid Arthritis
Ann. Clin. Lab. Sci., July 1, 2002; 32(3): 264 - 270.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.